ProfileGDS4718 / 243176_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 53% 73% 42% 54% 68% 58% 44% 47% 52% 60% 53% 67% 68% 67% 58% 60% 64% 61% 63% 48% 55% 52% 48% 52% 65% 54% 60% 56% 67% 52% 73% 47% 58% 65% 73% 49% 43% 51% 70% 54% 58% 56% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4954950
GSM549102patient 115, normal, homogenized [OPG study]5.6885753
GSM549104patient 119, normal, homogenized [OPG study]7.1665973
GSM549108patient 138, normal, homogenized [OPG study]5.1646342
GSM549119patient 077, normal, homogenized [OPG study]5.7390654
GSM549133patient 032, cancer, homogenized [OPG study]6.7280368
GSM549139patient 042, cancer, homogenized [OPG study]6.0067858
GSM549099patient 107, normal, homogenized [OPG study]5.2327544
GSM549109patient 139, normal, homogenized [OPG study]5.3723647
GSM549110patient 046, normal, homogenized [OPG study]5.6523152
GSM549114patient 063, normal, homogenized [OPG study]6.0656460
GSM549122patient 082, normal, homogenized [OPG study]5.6993453
GSM549134patient 033, cancer, homogenized [OPG study]6.6462967
GSM549136patient 036, cancer, homogenized [OPG study]6.7054268
GSM549140patient 044, cancer, homogenized [OPG study]6.6098467
GSM549111patient 047, normal, homogenized [OPG study]5.9930158
GSM549113patient 057, normal, homogenized [OPG study]6.1071260
GSM549132patient 031, cancer, homogenized [OPG study]6.4253164
GSM549137patient 038, cancer, homogenized [OPG study]6.2156961
GSM549142patient 047, cancer, homogenized [OPG study]6.3672963
GSM549100patient 110, normal, homogenized [OPG study]5.4040748
GSM549107patient 135, normal, homogenized [OPG study]5.7746555
GSM549115patient 068, normal, homogenized [OPG study]5.5948152
GSM549116patient 072, normal, homogenized [OPG study]5.3817448
GSM549120patient 078, normal, homogenized [OPG study]5.6075452
GSM549131patient 030, cancer, homogenized [OPG study]6.5192965
GSM549118patient 074, normal, homogenized [OPG study]5.7188454
GSM549129patient 027, cancer, homogenized [OPG study]6.184860
GSM549123patient 088, normal, homogenized [OPG study]5.8945956
GSM549124patient 006, cancer, homogenized [OPG study]6.6364867
GSM549126patient 015, cancer, homogenized [OPG study]5.5868152
GSM549128patient 025, cancer, homogenized [OPG study]7.2672973
GSM549103patient 117, normal, homogenized [OPG study]5.4061247
GSM549117patient 073, normal, homogenized [OPG study]5.9532358
GSM549138patient 041, cancer, homogenized [OPG study]6.5078465
GSM549141patient 045, cancer, homogenized [OPG study]7.2370573
GSM549130patient 028, cancer, homogenized [OPG study]5.4668949
GSM549101patient 111, normal, homogenized [OPG study]5.192243
GSM549105patient 128, normal, homogenized [OPG study]5.5956651
GSM549106patient 134, normal, homogenized [OPG study]6.9993670
GSM549112patient 048, normal, homogenized [OPG study]5.7142654
GSM549125patient 011, cancer, homogenized [OPG study]6.0266558
GSM549127patient 024, cancer, homogenized [OPG study]5.9241256
GSM549135patient 035, cancer, homogenized [OPG study]6.6698367